Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study
Autor: | Magdalena Cerdá, Daniel J. Tancredi, Stephen G. Henry, Garen J. Wintemute, Andrew Crawford, Susan L. Stewart, Iraklis Erik Tseregounis, Aaron B. Shev, Eryn Murphy, Brandon D.L. Marshall, James J Gasper |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Clinical Sciences Opioid Practice Patterns Logistic regression Drug Prescriptions 01 natural sciences Cohort Studies opioid analgesics Substance Misuse 03 medical and health sciences 0302 clinical medicine Clinical Research General & Internal Medicine long-term opioid use Odds Ratio Internal Medicine medicine Humans pain Prescription Drug Abuse 030212 general & internal medicine Practice Patterns Physicians' 0101 mathematics Medical prescription Child Original Research Analgesics Physicians' Receiver operating characteristic business.industry Incidence (epidemiology) 010102 general mathematics health policy Odds ratio Opioid-Related Disorders Analgesics Opioid Good Health and Well Being Pill Emergency medicine Prescription Drug Monitoring Programs Patient Safety Drug Abuse (NIDA only) business medicine.drug Cohort study |
Zdroj: | J Gen Intern Med Journal of general internal medicine, vol 36, iss 12 |
ISSN: | 1525-1497 0884-8734 |
DOI: | 10.1007/s11606-020-06555-x |
Popis: | BACKGROUND: Limiting the incidence of opioid-naïve patients who transition to long-term opioid use (i.e., continual use for > 90 days) is a key strategy for reducing opioid-related harms. OBJECTIVE: To identify variables constructed from data routinely collected by prescription drug monitoring programs that are associated with opioid-naïve patients’ likelihood of transitioning to long-term use after an initial opioid prescription. DESIGN: Statewide cohort study using prescription drug monitoring program data PARTICIPANTS: All opioid-naïve patients in California (no opioid prescriptions within the prior 2 years) age ≥ 12 years prescribed an initial oral opioid analgesic from 2010 to 2017. METHODS AND MAIN MEASURES: Multiple logistic regression models using variables constructed from prescription drug monitoring program data through the day of each patient’s initial opioid prescription, and, alternatively, data available up to 30 and 60 days after the initial prescription were constructed to identify probability of transition to long-term use. Model fit was determined by the area under the receiver operating characteristic curve (C-statistic). KEY RESULTS: Among 30,569,125 episodes of patients receiving new opioid prescriptions, 1,809,750 (5.9%) resulted in long-term use. Variables with the highest adjusted odds ratios included concurrent benzodiazepine use, ≥ 2 unique prescribers, and receipt of non-pill, non-liquid formulations. C-statistics for the day 0, day 30, and day 60 models were 0.81, 0.88, and 0.94, respectively. Models assessing opioid dose using the number of pills prescribed had greater discriminative capacity than those using milligram morphine equivalents. CONCLUSIONS: Data routinely collected by prescription drug monitoring programs can be used to identify patients who are likely to develop long-term use. Guidelines for new opioid prescriptions based on pill counts may be simpler and more clinically useful than guidelines based on days’ supply or milligram morphine equivalents. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-020-06555-x. |
Databáze: | OpenAIRE |
Externí odkaz: |